Healthcare Services

Rising biologics demand is driving growth in the cell-based assays market

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Cell Based Assays Market Be By 2030 Compared To Its 2026 Market Size?

The cell based assays market has experienced rapid expansion in recent years. It is projected to increase from $29.41 billion in 2025 to $33.21 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. This market’s historical growth can be attributed to increasing drug discovery activities, the expansion of in vitro research methodologies, the rising use of cell-based models in basic research, the availability of advanced assay consumables, and the growth of pharmaceutical R&D spending.

The cell based assays market is anticipated to experience significant expansion in the coming years. This market is projected to reach $54.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. The upward trend during the forecast period can be linked to the wider acceptance of AI-supported assay analysis, an increased need for intricate disease modeling, the broadening scope of personalized medicine investigations, the expanding application of laboratory automation, and greater financial commitments to sophisticated screening platforms. Key developments expected within the forecast timeframe involve the surging integration of high-throughput cell-based screening, the increasing deployment of automated cell handling mechanisms, a heightened requirement for predictive toxicology assays, the spread of label-free cell analysis techniques, and a stronger emphasis on cell models that are physiologically relevant.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Which Primary Drivers Are Impacting The Cell Based Assays Market Growth?

The cell-based assays market is anticipated to be driven by an increase in biologics sales. Biologics, also referred to as biological products, are medicines derived from living organisms, encompassing various products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Cell-based assays are vital in biologics for evaluating functionality, potency, safety, and bio-similarity. For instance, in October 2024, information from the Generics and Biosimilars Initiative, a Belgium-based organization providing scientific data on generic and biosimilar medicines, indicated that in 2023, two additional complex drugs, beyond the nine leading biologics, recorded significant sales. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, achieved sales of US$14 billion and US$7.2 billion, respectively. Therefore, the rise in electronic payment methods is driving the cell-based assays market.

What Are The Key Segment Divisions In The Cell Based Assays Market Segment Structure?

The cell based assays market covered in this report is segmented –

1) By Product And Service: Consumables, Instruments, Services, Software

2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies

3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users

Subsegments:

1) By Consumables: Cell Culture Media, Reagents And Kits, Cell Lines, Microplates

2) By Instruments: Microplate Readers, Flow Cytometers, Cell Imaging Systems, Automated Cell Culture Systems

3) By Services: Custom Assay Development, Contract Research Services

4) By Software: Data Analysis Software, Lab Management Software, Simulation And Modeling Software

Which Trends Are Shaping Growth In The Cell Based Assays Market?

Leading companies operating in the cell-based assays market are launching new platforms based on technologies such as cell-based phenotypic assay platforms to offer advanced solutions for drug discovery. A cell-based phenotypic assay platform is a system utilized in drug discovery that assesses cellular responses to compound treatments by integrating advanced imaging and analytical tools, enhanced by artificial intelligence. For instance, in June 2024, Sphere Fluidics, a UK-based life sciences R&D company, introduced Cyto-Cellect PLUS. Cyto-Cellect PLUS is a user-friendly Fluorescence Resonance Energy Transfer (FRET) assay that allows researchers to accurately measure IgG productivity with high sensitivity. Building on Sphere Fluidics’ original Cyto-Cellect Human IgG? Detection Kit, this enhanced version also detects both IgG ? and ? light chains, broadening its applicability. The assay is fully compatible with existing Cyto-Mine® functionality, facilitating single-cell dispensing into 96-well and 384-well plates. Additionally, it meets relevant regulatory standards by being free of animal origins, making it easy to integrate into current cell line development processes.

Which Organizations Are Engaged In The Cell Based Assays Market?

Major companies operating in the cell based assays market are Promega Corporation, Bio-Rad Laboratories Inc, PerkinElmer Inc, Abcam plc, Enzo Life Sciences Inc, Cell Signaling Technology Inc, Cisbio International LLC, Eurofins Scientific SE, Charles River Laboratories International Inc, Miltenyi Biotec GmbH, Lonza Group Ltd, Corning Incorporated, Becton Dickinson and Company, Danaher Corporation, GE HealthCare Technologies Inc, BioVision Inc, Biotium Inc, ProQinase GmbH, QGel SA, Cell Biolabs Inc

Get The Full Cell Based Assays Market Report:

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Which Region Represents The Largest Share Of The Cell Based Assays Market?

North America was the largest region in the cell-based assays market in 2025. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Based Assays Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Browse Through More Reports Similar to the Global Cell Based Assays Market 2026, By The Business Research Company

Cell Cultures Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cell Viability Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795